Literature DB >> 28575205

Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.

Mitsuru Ishii1, Hisashi Ogawa1, Takashi Unoki1, Yoshimori An1, Moritake Iguchi1, Nobutoyo Masunaga1, Masahiro Esato2, Yeong-Hwa Chun2, Hikari Tsuji3, Hiromichi Wada4, Koji Hasegawa4, Mitsuru Abe1, Masaharu Akao1.   

Abstract

BACKGROUND: Hypertension is considered a major risk factor of stroke and systemic embolism (SE) as well as bleeding in patients with atrial fibrillation (AF). The purpose of this study was to investigate the relationship of hypertension and systolic blood pressure (SBP) with the risk of stroke/SE or bleeding in AF patients.
METHODS: The Fushimi AF Registry, a community-based prospective survey, was designed to enroll all of the AF patients in Fushimi-ku, Kyoto. Fushimi-ku is densely populated with a total population of 283,000. Follow-up data were available for 3,713 patients (follow-up rate 90.0%) as of August 2015, and the median follow-up period was 1,035 days.
RESULTS: We compared the clinical backgrounds at baseline, and follow-up outcomes of AF patients between those with hypertension (HTN; n = 2,304, 62.1% of total) and those without (non-HTN; n = 1,409). History of hypertension was neither associated with the incidence of stroke/SE, ischemic stroke, hemorrhagic stroke nor major bleeding. However, when we divided the HTN group by baseline SBP ≥150 mm Hg (HTN-high blood pressure [HBP]: n = 305, 13.3% of HTN group) or <150 mm Hg (HTN-low blood pressure [LBP]: n = 1,983), HTN-HBP group was significantly associated with a higher incidence of both stroke/SE (hazard ratio [HR]: 1.74, 95% confidence interval [CI]: 1.08-2.72) and major bleeding (HR: 2.01, 95% CI: 1.21-3.23) compared with the non-HTN group. In contrast, HTN-LBP group was not associated with the risk of stroke/SE or major bleeding, compared with the non-HTN group.
CONCLUSION: The incidences of stroke/SE and bleeding were higher in AF and hypertension patients with elevated SBP. UMIN Clinical Trials Registry: UMIN000005834. © American Journal of Hypertension, Ltd 2017. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  atrial fibrillation; blood pressure; hypertension; stroke

Mesh:

Substances:

Year:  2017        PMID: 28575205     DOI: 10.1093/ajh/hpx094

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

1.  Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer's patients.

Authors:  Faez Saleh Al-Hamed; Stamatis Kouniaris; Iskandar Tamimi; Marie Lordkipanidzé; Sreenath Arekunnath Madathil; Abbas Kezouh; Igor Karp; Belinda Nicolau; Faleh Tamimi
Journal:  Alzheimers Dement (N Y)       Date:  2021-08-20

2.  Association between body mass index and the risk of bleeding in elderly patients with non-valvular atrial fibrillation taking dabigatran: a cohort study.

Authors:  Ming-Hui Li; Li-Hua Hu; Yu-Rong Xiong; Yu Yu; Wei Zhou; Tao Wang; Ling-Juan Zhu; Xi Liu; Hui-Hui Bao; Xiao-Shu Cheng
Journal:  J Geriatr Cardiol       Date:  2020-04       Impact factor: 3.327

3.  Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy.

Authors:  Ronald Galdamez; José A García; Marta Fernández; Catalina Robledano; Vanessa Agulló; Javier García-Abellán; Guillermo Telenti; Sergio Padilla; Félix Gutiérrez; Mar Masiá
Journal:  Open Forum Infect Dis       Date:  2019-11-13       Impact factor: 3.835

4.  Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke.

Authors:  Bilonda K Paulin; Kabulo K Cedric; Abdelhakam G Tamomh; Yang Dong Hui
Journal:  Int J Health Sci (Qassim)       Date:  2019 Nov-Dec

5.  Estrogen and estrogen receptors in kidney diseases.

Authors:  Hao-Yang Ma; Shuang Chen; Yang Du
Journal:  Ren Fail       Date:  2021-01-01       Impact factor: 2.606

6.  Anticoagulant Therapy for Frail Patients with Atrial Fibrillation.

Authors:  Hiroshi Hori; Takahiko Fukuchi; Hitoshi Sugawara
Journal:  Intern Med       Date:  2021-02-15       Impact factor: 1.271

7.  Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.

Authors:  Rungroj Krittayaphong; Satchana Pumprueg; Kasem Ratanasumawong; Poom Sairat; Gregory Y H Lip
Journal:  Clin Interv Aging       Date:  2021-10-12       Impact factor: 4.458

8.  Predictors of Smartphone and Tablet Use Among Patients With Hypertension: Secondary Analysis of Health Information National Trends Survey Data.

Authors:  Chinwe E Eze; Brady T West; Michael P Dorsch; Antoinette B Coe; Corey A Lester; Lorraine R Buis; Karen Farris
Journal:  J Med Internet Res       Date:  2022-01-24       Impact factor: 5.428

9.  Factors Associated with Nonachievement of Target Blood Pressure in Patients on Antithrombotic Therapy: A Real-World Study.

Authors:  Naoyuki Odaguchi; Atsushi Sakima; Tomohiro Yara; Isao Shiroma
Journal:  JMA J       Date:  2021-12-15

Review 10.  Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients.

Authors:  Jacopo Marazzato; Federico Blasi; Michele Golino; Paolo Verdecchia; Fabio Angeli; Roberto De Ponti
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.